Source: Annual Congress 2012 - Fungal, viral and other infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Simon, C. Panadero, E. Minchole, S. Fandos, A. Lasierra, M.A. Ruiz, E. Forcen, V. Moya, E. Vera, S. Bello (Zaragoza, Spain). Role of virus in community-acquired pneumonia (CAP). Eur Respir J 2012; 40: Suppl. 56, 1921

Member's Comments

No comment yet.

Related content which might interest you: Biomarkers in community-acquired pneumonia (CAP) Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Viral and mixed virus-bacteria community-acquired pneumonia (CAP) in hospitalized adults Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections Year: 2009 Role of viruses, alone and in association with bacteria, in adults hospitalized with community-acquired pneumonia (CAP) Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011 Epidemiology of community-acquired pneumonia (CAP) Source: International Congress 2015 – Russia Day: Community-acquired pneumonia (CAP) in adults Year: 2015 Atypical agents of community-acquired pneumonia (CAP) Source: Eur Respir J 2003; 22: Suppl. 45, 485s Year: 2003 Clostridium difficile infection following community-acquired pneumonia Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011 The severity of Pneumocystis pneumonia without human immunodeficiency virus infection (non-HIV PCP) might be underestimated by conventional diagnostic rules for community-acquired pneumonia (CAP) Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Biomarkers and severity in community-acquired pneumonia (CAP) Source: Annual Congress 2012 - Prognostic indices in respiratory infections Year: 2012 Legionella pneumonia in patients hospitalized with community-acquired pneumonia (CAP) in Norway Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012 The peculiarity of community-acquired pneumonia (CAP) express-diagnostic by means of bacterioscopy Source: Eur Respir J 2004; 24: Suppl. 48, 413s Year: 2004 Update on community-acquired pneumonia Source: International Congress 2017 – ME5 Update on community-acquired pneumonia Year: 2017 Detection of liver function in patients with severe community-acquired pneumonia (CAP) Source: Eur Respir J 2002; 20: Suppl. 38, 15s Year: 2002 Epidemiology of community-acquired pneumonia and nosocomial pneumonia Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Use of ceftriaxone/sulbactame for treatment of mild-to-severe community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Treatment of airways disease Year: 2009 Impact of aspiration pneumonia in community-acquired pneumonia and healthcare-associated pneumonia Source: Annual Congress 2012 - CT findings: educational posters Year: 2012 Community-acquired pneumonia (CAP) and pregnancy Source: Annual Congress 2009 - Pulmonary infections Year: 2009 Detection parachlamydia acanthamoeba and simkania negevensis in young patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2004; 24: Suppl. 48, 412s Year: 2004 Enhanced neutrophil response in patients with chronic bronchitis and community-acquired pneumonia (CAP) Source: Eur Respir J 2002; 20: Suppl. 38, 418s Year: 2002 Clinical significance of virus detected community-acquired pneumonia in adults Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit Year: 2018 Analysis of therapy of community-acquired pneumonia (CAP) at the COPD patients Source: Annual Congress 2011 - COPD management Year: 2011